Press Releases
-
Brooks Automation and Cleveland Clinic Celebrate Opening of Biobanking Facility
Brooks Automation and Cleveland Clinic have opened a new 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus.
Oct 7, 2021
-
New Range of Refrigerators Provide Enhanced Functionality for Secure Blood Storage
Thermo Fisher Scientific is announcing the launch of its TSB Series of blood bank refrigerators across Europe, the Middle East and Africa (EMEA).
Oct 11, 2021
-
ENPICOM participates in Inno4vac, a European new public-private partnership to innovate vaccine development
The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilized more than €33 million to support Inno4vac, a pioneering public-private partnership to accelerate vaccine R&D timelines. Launched on 1st September 2021, it focuses on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of novel vaccines.
Oct 6, 2021
-
NanoImaging Services Collaborates with Viva Biotech to Offer an Integrated CryoEM Gene-to-Structure Workflow to Streamline Target Discovery
NanoImaging Services, Inc. and Viva Biotech Holdings have announced a partnership agreement to develop a streamlined, cryoEM enabled gene-to-structure workflow, to ultimately accelerate medicinal chemistry analysis.
Oct 11, 2021
-
Targeted reduction of SARS-COV-2 viral load in the nose with photodisinfection may reduce severity of lower tract respiratory disease
Reducing COVID-19 effects with Photodisinfection – Results presented at the IDWeek 2021 conference - a joint meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP).
Oct 13, 2021
-
Ciox Digital Direct expands clinical data accessibility for Payers
Oct 18, 2021
-
BOC Sciences Expands Amino Acid Synthesis Services to Promote Peptide Drug R&D
Oct 20, 2021
-
Curebase, Checkable Medical Announce Joint Clinical Trial to Assess Effectiveness of At-home Strep Test Kit
Curebase, Checkable Medical Announce Joint Clinical Trial to Assess Effectiveness of At-home Strep Test Kit
Oct 18, 2021
-
CD Formulation Unveils Hygroscopicity Evaluation for Drug Formulation
Oct 18, 2021
-
Creative Bioarray Launches Cell Immortalization Services to Extend Replicative Capacity of Target Cells and Accelerate Biomedical Research
Oct 21, 2021
-
DDA Platform Releases In Vitro Permeability Assay to Evaluate Drug Permeability and Predict Drug Absorption
Oct 21, 2021
-
Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care, and Improve Patient Outcomes
Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care, and Improve Patient Outcomes
Oct 19, 2021
-
Creative Biogene Eatablished An Excellent Platform to Provide High Quality Virus-Like Particles
Oct 24, 2021
-
IntegrateRNA Launched Comprehensive LncRNA Pull-down Services: Supporting The Validation of LncRNA Biology
Oct 24, 2021
-
Calyx RIM Selected by Top 10 Global Pharmaceutical Company for Five-Year Agreement
Regulatory publishing solution selected based on reliability and innovation
Oct 24, 2021
-
BioIVT to Showcase Drug Discovery Research Advances Using Novel Hepatotoxicity Models
Researchers will discuss how they employed HEPATOPAC® and HEPATOMUNE® cultures in their disease modeling, lead selection, and ADME evaluation programs.
Oct 24, 2021
-
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category
Oct 24, 2021
-
The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform
Oct 24, 2021
-
Profacgen Enables Custom Bioinformatics Software Development for Researchers Worldwide
Oct 25, 2021
-
CD ComputaBio Announces 3D-QSAR Service for Drug Design and Screening
CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company has recently launched 3D-QSAR services for scientists to accelerate the drug development process.
Oct 18, 2021






